We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Your comments on the proposed adoption or non-adoption of these EU guidelines, particularly your advice on whether you support the proposed action, would be appreciated.
Comments may be sent by email or mail and should include your full contact details.
The email address for comments is: euguidelines@tga.gov.au
The postal address for comments is:
EU/ICH Guidelines Coordinator
Office of Medicines Authorisation
Therapeutic Goods Administration
PO Box 100
WODEN ACT 2606
Guidelines proposed for adoption
There are currently no EU guidelines proposed for adoption
Guidelines proposed for non-adoption
There are currently no EU guidelines proposed for non-adoption